Research Analysts Set Expectations for ELDN FY2025 Earnings
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Cantor Fitzgerald lifted their FY2025 EPS estimates for Eledon Pharmaceuticals in a research report issued on Thursday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will earn ($0.73) per share for the year, up from their previous estimate of ($1.23). The consensus estimate […]
More Stories
Recurring Unemployment Claims Decline to 1-Month Low
By Andrew Moran In a potential signal that the U.S. labor market could be on the cusp of renewed hiring...
US Treasury to Allow Resale of Venezuelan Oil to Cuba to Ease Island’s Fuel Crunch
By Kimberly Hayek The U.S. Treasury Department on Wednesday announced a new licensing policy to streamline the resale of Venezuelan...
Enterprise Use Cases Driving Demand for AI Agent Development Services in 2026
By the end of 2026, Gartner anticipates 40% of enterprise applications will integrate AI agents. A dramatic increase from today’s...
Top 15 Romantic Comedy Movies on Netflix That Will Steal Your Heart
Are you looking for some romantic films that you can watch with your loved ones? Don’t worry, I will not...
Vance Announces New Phase of Fraud Investigations, Withholds $259 Million in Medicaid Funds From Minnesota
By Travis Gillmore WASHINGTON—Vice President JD Vance announced new efforts to combat fraud nationwide during a press conference on Feb....
BMW Recalls Nearly 59,000 US Vehicles for Wiring Harness Short-Circuit Risk
By Mary Prenon Luxury auto manufacturer BMW of North America has issued a recall of 58,713 vehicles for a possible...